USPTO trademark

CONTRA-MAB

Under examinationUSPTOWord markClass 42

"CONTRA-MAB" is a word mark owned by Inhibrx Biosciences, Inc., filed at the USPTO on March 17, 2026. It is under examination and covers class 42 (Computer and Scientific Services).

View Inhibrx Biosciences, Inc. portfolioGet this data via the API
Official USPTO record
CONTRA-MAB trademark as filed
As filed with the USPTO
Status
Under examination
Since September 8, 2026
Filed
March 17, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99706801
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns CONTRA-MAB

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Inhibrx Biosciences, Inc.

INBX · La Jolla, United States

14 trademarks in the portfolioView company

Representative

Andrew D. Skale

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Goods and services

What the mark covers

The products and services CONTRA-MAB is filed for, grouped by Nice class.

  • Discovery and development of engineered modular protein formats being drug discovery services; Discovery and development of new drug candidate material, namely, drug discovery services; Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals; Drug Discovery services, and research, and development services in the field of pharmaceutical preparations and substances; Drug Discovery services, and research, and development of therapeutic antibodies and pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical, therapeutic, and diagnostic drug discovery services; Medical research in the field nature of engineered modular protein formats

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas/email correspondence entered
  2. Correspondence received in law office
  3. Teas response to office action received
  4. Notification of non-final action e-mailed
  5. Non-final action e-mailed
  6. Non-final action written
  7. Use amendment accepted
  8. Assigned to examiner
  9. New application office supplied data entered
  10. Amendment to use processing complete

4 earlier steps on the official record.

FAQ

About CONTRA-MAB

Who owns the trademark "CONTRA-MAB"?

The USPTO trademark "CONTRA-MAB" (application 99706801) is owned by Inhibrx Biosciences, Inc.

What is the status of "CONTRA-MAB"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CONTRA-MAB and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d3f15-15e5-759a-b042-fc462a594d25
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d3f15-15e5-759a-b042-fc462a594d25",
  "object": "trademark",
  "mark_text": "CONTRA-MAB",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99706801",
  "filing_date": "2026-03-17",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "INHIBRX BIOSCIENCES, INC.",
      "entity_id": "ent_019eb719-f44e-7368-8d14-35e37951bef9"
    }
  ]
}